CytomX Therapeutics (CTMX) Asset Utilization Ratio (2016 - 2025)
CytomX Therapeutics (CTMX) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.68 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Asset Utilization Ratio fell 19.71% year-over-year to 0.68, compared with a TTM value of 0.68 through Sep 2025, down 19.71%, and an annual FY2024 reading of 0.86, up 95.86% over the prior year.
- Asset Utilization Ratio was 0.68 for Q3 2025 at CytomX Therapeutics, down from 1.03 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.35 in Q1 2025 and bottomed at 0.02 in Q1 2021.
- Average Asset Utilization Ratio over 5 years is 0.44, with a median of 0.27 recorded in 2023.
- The sharpest move saw Asset Utilization Ratio crashed 80.35% in 2021, then skyrocketed 754.65% in 2022.
- Year by year, Asset Utilization Ratio stood at 0.13 in 2021, then increased by 8.41% to 0.14 in 2022, then surged by 243.17% to 0.48 in 2023, then skyrocketed by 122.38% to 1.06 in 2024, then plummeted by 35.94% to 0.68 in 2025.
- Business Quant data shows Asset Utilization Ratio for CTMX at 0.68 in Q3 2025, 1.03 in Q2 2025, and 1.35 in Q1 2025.